S

    Si-Bone Inc (SIBN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $19.02
    -0.19 (-0.99%)

    Market Cap: $852.45M

    Last updated: Sep 02, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    66%(21/32)
    Avg Surprise
    +10.05%
    Streak
    16 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.13
    Range$-0.17 - $-0.07
    8 analysts
    EPS Revisions
    2
    0
    7d
    1
    4
    30d
    EPS Estimate Drift
    90d ago$-0.11+10.8%
    60d ago$-0.13-1.5%
    30d ago$-0.13-1.5%
    7d ago$-0.12+3.4%
    Current$-0.13
    Revenue Consensus
    $55M
    Range$55M - $56M
    9 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.07
    Range$0.02 - $0.11
    8 analysts
    Revenue Consensus
    $70M
    Range$70M - $71M
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.07---
    Sep 26EST
    		-$-0.13---
    Jun 26
    Reported Aug 3
    		$-0.09$-0.15+40.00%Beat+35.7%
    Mar 26
    Reported May 11
    		$-0.10$-0.19+47.37%Beat+33.3%
    Dec 25
    Reported Feb 23
    		$-0.04N/A+69.23%Beat+63.6%
    Sep 25
    Reported Nov 10
    		$-0.11$-0.16+31.25%Beat+31.3%
    Jun 25
    Reported Aug 4
    		$-0.14$-0.18+22.22%Beat+36.4%
    Mar 25
    Reported May 5
    		$-0.15$-0.22+31.82%Beat+44.4%
    Dec 24
    Reported Feb 24
    		$-0.11$-0.13+18.09%Beat+59.3%
    Sep 24
    Reported Nov 12
    		$-0.16$-0.24+33.33%Beat+36.0%
    Jun 24
    Reported Aug 5
    		$-0.22$-0.28+21.43%Beat+26.7%
    Mar 24
    Reported May 6
    		$-0.27$-0.31+12.90%Beat+15.6%
    Dec 23
    Reported Feb 26
    		$-0.27$-0.28+3.57%Beat+15.6%
    Sep 23
    Reported Nov 6
    		$-0.25$-0.34+26.47%Beat+39.0%
    Jun 23
    Reported Aug 7
    		$-0.30$-0.40+25.00%Beat+44.4%
    Mar 23
    Reported May 1
    		$-0.32$-0.42+23.81%Beat+38.5%
    Dec 22
    Reported Feb 27
    		$-0.32$-0.40+20.00%Beat+25.6%
    Sep 22
    Reported Nov 7
    		$-0.41$-0.47+12.77%Beat+14.6%
    Jun 22
    Reported Aug 8
    		$-0.54$-0.49-10.20%Miss-28.6%
    Mar 22
    Reported May 9
    		$-0.52$-0.43-20.93%Miss-40.5%
    Dec 21
    Reported Feb 28
    		$-0.43$-0.39-10.26%Miss-53.6%
    Sep 21
    Reported Nov 8
    		$-0.48$-0.41-17.07%Miss-45.5%
    Jun 21
    Reported Aug 2
    		$-0.42$-0.39-7.69%Miss+4.5%
    Mar 21
    Reported May 3
    		$-0.37$-0.39+5.13%Beat+21.3%
    Dec 20
    Reported Mar 8
    		$-0.28$-0.30+6.67%Beat+22.2%
    Sep 20
    Reported Nov 2
    		$-0.33$-0.42+21.43%Beat+28.3%
    Jun 20
    Reported Aug 3
    		$-0.44$-0.63+30.16%Beat-25.7%
    Mar 20
    Reported May 4
    		$-0.47$-0.38-23.68%Miss-23.7%
    Dec 19
    Reported Mar 9
    		$-0.36$-0.35-2.86%Miss-63.6%
    Sep 19
    Reported Nov 11
    		$-0.46$-0.37-24.32%Miss-53.3%
    Jun 19
    Reported Aug 6
    		$-0.35$-0.35+0.00%Beat-84.2%
    Mar 19
    Reported May 8
    		$-0.38$-0.25-52.00%Miss-26.7%
    Dec 18
    Reported Mar 7
    		$-0.22$-0.21-4.76%Miss-
    Sep 18
    Reported Oct 18
    		$-0.30$-0.28-7.14%Miss-
    Jun 18
    Reported Aug 29
    		$-0.19$0.00N/AMiss-
    Mar 17
    Reported Jun 29
    		$-0.30$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-55.94EV/EBITDA-14.15x
    Price/FCF-192.83xFCF Yield-0.52%
    Profitability
    Profit Margin-6.85%Operating Margin-8.58%
    ROE-8.30%ROIC-6.44%
    Financial Health
    Debt/Equity0.20xInterest Coverage-7.13x
    Current Ratio9.15xQuick Ratio7.55x
    Trading Statistics
    Beta0.70Avg Volume540.06K
    52-Week High$21.8952-Week Low$11.48

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$19.44
    SMA 20$19.04
    SMA 50$17.91
    SMA 200$16.37
    EMA 10$19.24
    EMA 20$18.95
    EMA 50$17.92
    EMA 200$16.43

    MACD

    Line: 0.46Signal: 0.55Hist: -0.10

    ADX

    ADX: 38.6+DI: 26.4-DI: 13.2

    Aroon & PSAR

    Aroon Up80.0
    Aroon DownN/A
    PSAR$20.17

    Bollinger Bands

    Upper Band$20.07
    Lower Band$18.01
    %B Position1083%(Upper)
    Band Width0.49

    RSI (14-Day)

    Neutral
    54.3

    Momentum Oscillators

    Stoch %K39.4
    Stoch %D49.0
    Williams %R-67.0
    ROC (10d)1.8%
    Momentum0.33
    CCI (20d)-4.7
    MFI (14d)43.3

    Volatility Measures

    ATR (14d)$0.66(3.5%)
    StdDev (20d)0.52
    Hist Vol27.5%(Moderate)

    Volume Flow

    VWAP$19.00
    OBV1.9M
    AD Line3.2M
    CMF (20d)0.040

    Volume Metrics

    Avg Vol (20d)526.4K
    Vol Ratio0.6x
    VWMA (20d)$19.09

    Pivot Points

    R3$19.97
    R2$19.79
    R1$19.50
    Pivot Point$19.32
    S1$19.03
    S2$18.85
    S3$18.56

    Advanced Oscillators

    TSI20.75
    Ultimate Osc42.2
    KST99.64

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$56.01M$52.59M$56.35M$48.66M$48.63M$47.29M$49.00M$40.34M$39.97M$37.87M$38.86M$34.01M
    Cost of Revenue$11.46M$10.64M$11.82M$9.81M$9.82M$9.60M$10.22M$8.44M$8.39M$8.00M$10.18M$7.04M
    Gross Profit$44.55M$41.94M$44.53M$38.85M$38.81M$37.70M$38.78M$31.90M$31.58M$29.86M$28.68M$26.97M
    Operating Expenses$49.35M$47.04M$46.99M$44.23M$45.81M$45.17M$44.27M$39.54M$41.65M$41.91M$41.18M$38.14M
    R&D$5.22M$4.19M$4.36M$4.24M$4.31M$4.53M$3.87M$3.99M$4.35M$4.34M$4.16M$3.92M
    SG&A$10.11M$10.04M$9.82M$10.03M$10.72M$9.96M$9.15M$8.10M$8.33M$8.18M$8.08M$7.71M
    Operating Income$-4,806,000$-5,093,000$-2,463,000$-5,383,000$-7,004,000$-7,480,000$-5,494,000$-7,633,000$-10,078,000$-12,043,000$-12,506,000$-11,169,000
    Interest Income$1.33M$1.35M$1.45M$1.51M$1.52M$1.59M$1.78M$1.94M$2.02M$2.11M$2.23M$2.17M
    Interest Expense$598,000$592,000$630,000$670,000$666,000$662,000$795,000$884,000$880,000$881,000$890,000$884,000
    Income Before Tax$-4,088,000$-4,334,000$-1,672,000$-4,538,000$-6,152,000$-6,542,000$-4,495,000$-6,575,000$-8,939,000$-10,904,000$-10,983,000$-10,022,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-4,088,000$-4,334,000$-1,644,000$-4,566,000$-6,152,000$-6,542,000$-4,495,000$-6,575,000$-8,939,000$-10,904,000$-10,983,000$-10,022,000
    EBITDA$-3,629,000$-4,010,000$-1,407,000$-4,568,000$-6,432,000$-7,081,000$-5,431,000$-7,735,000$-10,497,000$-12,566,000$-12,297,000$-10,905,000
    EBIT$-4,822,000$-5,092,000$-2,463,000$-5,383,000$-7,006,000$-7,472,000$-5,484,000$-7,627,000$-10,074,000$-12,136,000$-12,321,000$-11,312,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SIBN

    News

    SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026

    SI-BONE, Inc. (Nasdaq: SIBN) announced its participation in the 24th Annual Morgan Stanley Global Healthcare Conference. The company's management will host a fireside chat on September 14, 2026, at 8:30 a.m. Pacific Time/11:30 a.m. Eastern Time. The conference will take place in New York, NY.

    Barchart.com•8/31/26•
    Neutral

    Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?

    Si-Bone (SIBN) has been identified as a strong momentum stock with a Zacks Rank of #2 (Buy) and a Momentum Style Score of B. The article highlights its recent positive price performance, outperforming both its industry and the S&P 500 over various periods. Additionally, positive earnings estimate revisions further support its promising outlook for investors seeking near-term growth.

    Yahoo Finance•8/25/26•
    Bullish

    SI-BONE officer plans $232K sale of 11,636 shares | SIBN SEC Filing - Form 144

    An officer at SI-BONE, Inc. (SIBN), Anshul Maheshwari, has filed a Form 144 notice to sell 11,636 shares of common stock, valued at approximately $232,254.56, through Morgan Stanley Smith Barney LLC. The sale is planned for on or before August 24, 2026, on NASDAQ. These shares were acquired from the vesting of restricted stock units (RSUs) and performance stock units (PSUs) between January 1, 2025, and February 15, 2026.

    Stock Titan•8/24/26•
    Somewhat-Bearish

    SI-BONE (NASDAQ: SIBN) trust to sell 25,972 shares under Rule 144

    The DAVID & LAURA FRANCIS JOINT REV TRU/A DTD 01/03/2003, associated with SI-BONE, Inc. (SIBN), has filed to sell 25,972 shares of common stock under Rule 144. These shares were acquired through the vesting of restricted stock units between May 15, 2021, and November 15, 2025. The filing also details prior sales made by the trust and Laura Francis, including significant Rule 10b5-1 transactions in August 2026.

    Stock Titan•8/24/26•
    Neutral

    This Insider Has Just Sold Shares In SI-BONE

    SI-BONE's CEO & Director, Laura Francis, recently sold US$279k worth of stock at US$18.66 per share, reducing her total holding by 2.8%. This follows a larger sale earlier in the year of US$1.4m worth of shares at a lower price of US$15.44. While insiders own about 3.6% of the company, the consistent selling without any purchases suggests caution for potential investors.

    Simply Wall Street•8/23/26•
    Somewhat-Bearish

    Frequently Asked Questions About SIBN

    Does SIBN pay dividends?
    Si-Bone Inc (SIBN) does not currently pay a regular dividend.
    What is SIBN's market cap?
    Si-Bone Inc (SIBN) has a market capitalization of $852.45M with a current stock price of $19.02.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In